Gilead's remdesivir shows promise in COVID-19 study on monkeys

The Jerusalem Post

Remdesivir is the first drug to show improvement in COVID-19 in human trials, and its progress in clinical studies is being closely watched as nations look for a treatment for the disease. https://www.jpost.com/health-science/gileads-remdesivir-shows-promise-in-covid-19-study-on-monkeys-630841